The Pro-Tumoral Activity of Heparan Sulfate 3--Sulfotransferase 3B (HS3ST3B) in Breast Cancer MDA-MB-231 Cells Is Dependent on the Expression of Neuropilin-1

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2018 Oct 27

PMID 30360368

Citations 5

Authors

Charles Hellec

Mariama Diawara

Mathieu Carpentier

Agnes Denys

Fabrice Allain

Affiliations

Soon will be listed here.

Abstract

Heparan sulfate 3--sulfotransferases (HS3STs) catalyze the maturation step of heparan sulfate (HS) 3--sulfation. This modification is relatively rare. Moreover, only a few biological processes have been described to be influenced by 3--sulfated HS, and few ligands have been identified so far. Among them, neuropilin-1 (Nrp1) was reported to exhibit tumor-promoting properties by enhancing the action of various growth factors. We recently demonstrated that transient overexpression of HS3ST2, 3B or 4 enhanced the proliferation of breast cancer MDA-MB-231 cells and promote efficient protection against pro-apoptotic stimuli. Hence, we hypothesized that the pro-tumoral activity of these HS3STs could depend on the expression of Nrp1. To test this, MDA-MB-231 cells were stably transfected with a construct encoding HS3ST3B and the expression of Nrp1 was down-regulated by RNA interference. First, we confirmed that stable expression of HS3ST3B effectively increased cell proliferation and viability. Silencing the expression of Nrp1 markedly attenuated the promoting effects of HS3ST3B, while the same treatment had only a moderate effect on the behavior of the parental cells. Altogether, our findings support the idea that the tumor-promoting effects of HS3ST3B could be dependent on the expression of Nrp1 in cancer cells.

Citing Articles

Neuropilin (NRPs) Related Pathological Conditions and Their Modulators.

Broz M, Kolaric A, Jukic M, Bren U Int J Mol Sci. 2022; 23(15).

PMID: 35955539 PMC: 9368954. DOI: 10.3390/ijms23158402.

Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality.

Ma Z, Li N, Zhang B, Hui Y, Zhang Y, Lu P J Nanobiotechnology. 2020; 18(1):123.

PMID: 32887626 PMC: 7650261. DOI: 10.1186/s12951-020-00681-8.

The Emerging Roles of Heparan Sulfate 3--Sulfotransferases in Cancer.

Denys A, Allain F Front Oncol. 2019; 9:507.

PMID: 31249810 PMC: 6582251. DOI: 10.3389/fonc.2019.00507.

Long Non-coding RNA DLEU1 Promotes Cell Proliferation, Invasion, and Confers Cisplatin Resistance in Bladder Cancer by Regulating the miR-99b/HS3ST3B1 Axis.

Li Y, Shi B, Dong F, Zhu X, Liu B, Liu Y Front Genet. 2019; 10:280.

PMID: 30984249 PMC: 6449426. DOI: 10.3389/fgene.2019.00280.

Introduction to the Molecules Special Edition Entitled '': Some Outstanding Questions in Heparan Sulfate and Heparin Research.

Yates E, Gallagher J, Guerrini M Molecules. 2019; 24(7).

PMID: 30974725 PMC: 6479682. DOI: 10.3390/molecules24071399.

References

Sikora A, Hellec C, Carpentier M, Martinez P, Delos M, Denys A . Tumour-necrosis factor-α induces heparan sulfate 6-O-endosulfatase 1 (Sulf-1) expression in fibroblasts. Int J Biochem Cell Biol. 2016; 80:57-65. DOI: 10.1016/j.biocel.2016.09.021. View

Miyamoto K, Asada K, Fukutomi T, Okochi E, Yagi Y, Hasegawa T . Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene. 2003; 22(2):274-80. DOI: 10.1038/sj.onc.1206146. View

Mochizuki H, Yoshida K, Gotoh M, Sugioka S, Kikuchi N, Kwon Y . Characterization of a heparan sulfate 3-O-sulfotransferase-5, an enzyme synthesizing a tetrasulfated disaccharide. J Biol Chem. 2003; 278(29):26780-7. DOI: 10.1074/jbc.M301861200. View

Biroccio A, Cherfils-Vicini J, Augereau A, Pinte S, Bauwens S, Ye J . TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nat Cell Biol. 2013; 15(7):818-28. DOI: 10.1038/ncb2774. View

Dunn G, Bruce A, Ikeda H, Old L, Schreiber R . Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002; 3(11):991-8. DOI: 10.1038/ni1102-991. View

Raimondi C, Ruhrberg C . Neuropilin signalling in vessels, neurons and tumours. Semin Cell Dev Biol. 2013; 24(3):172-8. DOI: 10.1016/j.semcdb.2013.01.001. View

Shukla D, Liu J, Blaiklock P, Shworak N, Bai X, Esko J . A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 1999; 99(1):13-22. DOI: 10.1016/s0092-8674(00)80058-6. View

Thacker B, Seamen E, Lawrence R, Parker M, Xu Y, Liu J . Expanding the 3-O-Sulfate Proteome--Enhanced Binding of Neuropilin-1 to 3-O-Sulfated Heparan Sulfate Modulates Its Activity. ACS Chem Biol. 2016; 11(4):971-80. PMC: 5450942. DOI: 10.1021/acschembio.5b00897. View

Liu J, Shworak N, Fritze L, Edelberg J, Rosenberg R . Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. J Biol Chem. 1996; 271(43):27072-82. DOI: 10.1074/jbc.271.43.27072. View

10.

Sikora A, Delos M, Martinez P, Carpentier M, Allain F, Denys A . Regulation of the Expression of Heparan Sulfate 3-O-Sulfotransferase 3B (HS3ST3B) by Inflammatory Stimuli in Human Monocytes. J Cell Biochem. 2015; 117(7):1529-42. DOI: 10.1002/jcb.25444. View

11.

West D, Rees C, Duchesne L, Patey S, Terry C, Turnbull J . Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem. 2005; 280(14):13457-64. DOI: 10.1074/jbc.M410924200. View

12.

Esko J, Selleck S . Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem. 2002; 71:435-71. DOI: 10.1146/annurev.biochem.71.110601.135458. View

13.

Hellec C, Delos M, Carpentier M, Denys A, Allain F . The heparan sulfate 3-O-sulfotransferases (HS3ST) 2, 3B and 4 enhance proliferation and survival in breast cancer MDA-MB-231 cells. PLoS One. 2018; 13(3):e0194676. PMC: 5856405. DOI: 10.1371/journal.pone.0194676. View

14.

Bui C, Ouzzine M, Talhaoui I, Sharp S, Prydz K, Coughtrie M . Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells. FASEB J. 2009; 24(2):436-50. DOI: 10.1096/fj.09-136291. View

15.

Miao H, Lee P, Lin H, Soker S, Klagsbrun M . Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 2000; 14(15):2532-9. DOI: 10.1096/fj.00-0250com. View

16.

Vijaya Kumar A, Salem Gassar E, Spillmann D, Stock C, Sen Y, Zhang T . HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression. Int J Cancer. 2014; 135(11):2579-92. DOI: 10.1002/ijc.28921. View

17.

Mitsiades C, Mitsiades N, Koutsilieris M . The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets. 2004; 4(3):235-56. DOI: 10.2174/1568009043333032. View

18.

Wang Z, Hsieh P, Xu Y, Thieker D, Chai E, Xie S . Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate. J Am Chem Soc. 2017; 139(14):5249-5256. PMC: 5624809. DOI: 10.1021/jacs.7b01923. View

19.

Martinez P, Denys A, Delos M, Sikora A, Carpentier M, Julien S . Macrophage polarization alters the expression and sulfation pattern of glycosaminoglycans. Glycobiology. 2014; 25(5):502-13. DOI: 10.1093/glycob/cwu137. View

20.

Aung N, Ohe R, Meng H, Kabasawa T, Yang S, Kato T . Specific Neuropilins Expression in Alveolar Macrophages among Tissue-Specific Macrophages. PLoS One. 2016; 11(2):e0147358. PMC: 4764655. DOI: 10.1371/journal.pone.0147358. View